Vinpocetine has been on the market as a dietary supplement for approximately the last 20 years. That could soon change thanks to a Federal Register notice that was published in September by FDA.
In this video, INSIDER explores:
-- FDA’s reasoning for its tentative conclusions that vinpocetine shouldn’t remain on the market as a dietary supplement;
-- reaction from trade associations to the Federal Register notice; and
-- a silver lining to the development for industry.